This is the second part of our interview, which dives deeper into the topic of PGT-A on Trial with Dr. Norbert Gleicher and Allison Freeman, the lead attorney behind a wave of groundbreaking class-action lawsuits targeting the PGT-A industry. From the misleading marketing claims to the emotional fallout experienced by hundreds of patients, this candid conversation continues to peel back the layers of an industry under fire.

This episode is perfect for anyone undergoing or considering IVF, as well as clinicians, advocates, and journalists following the future of reproductive medicine. After years of treatments, including IVF, Allison Freeman is a proud member and advocate of the fertility community. Utilizing her personal experience and law license, she began representing others during their fertility journeys and is at the forefront of issues related to treatments. She shares information on fertility, IVF, and advocacy on instagram at @ivf_advocate. She can also be reached at https://www.theivfadvocate.com or by email at allison@constable-law.com.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork

In this episode, Dr. Norbert Gleicher dives into the topic of egg donation specifically providing insight into the key differences between using frozen vs fresh donor eggs. With expert clinical experience and an extensive background in research, Dr. Gleicher explains how each option may impact success rates, treatment timing, and overall pregnancy outcomes.

If you’re considering egg donation or want a better understanding of how donor egg choices can affect fertility treatment, this video offers medically grounded explanations to help you make informed decisions.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork

In this episode, Dr. Norbert Gleicher talks about the impact of advanced paternal age on sperm quality and quantity. He provides an overview for anyone interested in learning more about male reproductive health and discusses why paternal age can play a role in fertility. The video highlights that fertility is not only a woman’s issue and that male factors are also an important part of the conversation.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork

It has been more than 40 years since the first IVF baby was born and today, millions of babies are born using assisted reproductive technology. Throughout the years, new studies and research have been conducted which contributes to the advancement of reproductive medicine. One topic that has become popular is the process of how follicle development is monitored and how to determine the timing of the egg retrieval.

HIER is based on the understanding that follicle maturity is a biological process, not just a measurement. Instead of treating all patients with the same protocol, the process of HIER tailors the timing of the ovulation trigger and egg retrieval to the individual patient.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork

In this episode, Dr. Norbert Gleicher discusses artificial intelligence (AI) and infertility treatment. He goes into depth regarding the benefits of AI as well as the limitations. He highlights the importance of understanding when and how to use AI appropriately and effectively in medicine.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork

In this video, Dr. Norbert Gleicher explains the key differences between PGT-A, PGT-M, and PGD, which are all types of preimplantation genetic testing that is used by many fertility clinics during IVF. Many patients hear these terms throughout their journey, but are not quite sure what they really mean or when each test is actually helpful. Dr. Gleicher breaks down the science of each of these tests and gives his insights into which ones are useful.

This discussion may help clarify common misconceptions, outline the limitations of each approach, and provide important context for patients considering genetic testing as part of their IVF treatment.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork

As we begin a new year, Dr. Norbert Gleicher shares what truly sets CHR apart and what patients can expect when starting treatment with us.

CHR is known for working with patients who often need more individualized care, including women over 40, patients with diminished ovarian reserve, repeat IVF failures, and complex medical histories. In this video, Dr. Gleicher explains why CHR does not believe in one size fits all fertility treatment and how every patient’s care is built around their specific biology, history, and goals.

You will hear what happens after your initial consultation, how in depth diagnostic workups guide treatment decisions, and why CHR closely monitors patients throughout stimulation to adjust protocols in real time. Dr. Gleicher also discusses CHR’s approach to customized stimulation, timing of retrieval, and individualized embryo transfer decisions, including why some patients benefit from Day 3 transfers while others do not.

This offers a clear look at CHR’s philosophy, our commitment to questioning industry norms, and what patients can expect when choosing a clinic that prioritizes thoughtful, data driven, and deeply personalized care.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork

The New Year often comes with the phrase “New Year, New You,” but for those navigating fertility challenges, that message can feel disheartening, like you are constantly starting from scratch. In this special New Year’s Day episode, Dr. Norbert Gleicher reframes the conversation: you are not starting over, you are starting forward.

Drawing on decades of experience, Dr. Gleicher explains how every appointment, test, and treatment builds knowledge and resilience that carry into the future. He discusses why progress in fertility care is rarely linear, how individualized treatment plans matter more than cookie-cutter timelines, and how patients can embrace the New Year with both honesty and hope.

This episode is a reminder that your journey is not erased by setbacks or by the turning of the calendar. Each step brings you forward—and this year can hold the possibility of new beginnings and new family.

Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.

Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.

Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.

Website: www.thechr.com

Facebook: https://www.facebook.com/chrnewyork

Instagram: https://www.instagram.com/chrnewyork/

Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/

Pinterest: https://www.pinterest.com/CenterforHumanReproduction/

TikTok: https://www.tiktok.com/@chrnewyork